"MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is the evaluation of the effect of metformin among the patients without
diabetes, on the incidence of reintervention, unplanned revascularization, after full
percutaneous coronary revascularization as a result of the first episode of the acute
coronary syndrome (ACS).